Parham Academy LLC
European Academy of Biomedical Sciences


Our news & hot issues


ISI Impact factor= 5.49 (Q1)



(Reverse chronological order)

Molecular modelling, molecular dynamics simulations and in vitro evaluation of Berberine as an inhibitor of MAP kinase and PI3K pathway. (2017: Accepted as Poster presentation; Role: presenter; Poster Session Title: Experimental/Molecular Therapeutics, Pharmacogenesis I), In: "EACR-AACR-SIC Special Conference 2017: The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic", 25th June, Florence, Italy.

Molecular modelling of berberine derivatives as inhibitors of smoothened receptor using a new drug discovery script for a large numbers of compounds. (2017: Poster presentation; Role: presenter; Poster Session Title: Experimental/Molecular Therapeutics, Pharmacogenesis I), In: "EACR-AACR-SIC Special Conference 2017: The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic", 25th June, Florence, Italy.

Is it the right way to use intercalating agents as inhibitors of MAP kinase pathway? A challenging issue using berberine with dual cellular functionality applied in breast cancer cell models. (2017: Poster presentation; Role: presenter), In: "Tumour Microenvironment – Basic Science to Novel Therapies", 15th June 2017, Nottingham, UK.

Molecular modelling and molecular dynamics simulations of a new berberine derivative as a dual RAF inhibitor for treatment of drug resistance acquired in melanoma. (2016: Oral presentation; Role: Presenter), In: "Pharmacology", British Pharmacological Society, 13th December, London, UK. (Abstract)

Tissue regeneration in mammals: Role of Oct4 gene expression in treatment of infectious diseases. (2010: Poster presentation; Role: Presenter) "10th International MEEGID Conference (Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases)", Nov. 2010, Amsterdam, Netherlands (Elsevier).

A new cell line detected in mouse: A novel theory of stem cell applications in tissue regeneration. (2010: Oral presentation; Role: Presenter) "11th Iranian Genetics Congress", Shahid Beheshti University, May. 2010, Tehran.
ASPET annual meeting




Author watson Home 15:42:17 | | | printer friendly | | create pdf of this news item


Our article: Therapeutic miRNAs


 Pharmacological Research




Headlines





Date published: not known
Details

»Nocturnal refuge
»A scene-internalizing computer program
»An intrinsic magnetic tunnel junction
»Lower-energy photons do the work, too
»Seeing ghosts
»Mesoamerican turquoise locally sourced
»Disentangling specific memories
»Designer bugs as drugs
»Modeling memory differentiation in T cells
»Chronic stress as a survival tactic


Date published: not known
Details

»Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1 [Articles]
The insulin receptor (IR) is a ligand-activated receptor tyrosine kinase that has a key role in met ...
»Ligand-Specific Signaling Profiles and Resensitization Mechanisms of the Neuromedin U2 Receptor [Articles]
The structurally related, but distinct neuropeptides, neuromedin U (NmU) and neuromedin S (NmS) are ...
»Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity [Articles]
Species differences in renal drug transporters continue to plague drug development with animal mode ...
»Thyroid Hormones Are Transport Substrates and Transcriptional Regulators of Organic Anion Transporting Polypeptide 2B1 [Articles]
Levothyroxine replacement therapy forms the cornerstone of hypothyroidism management. Variability i ...
»Cysteine Scanning Mutagenesis of TM4b-4c Loop of Glutamate Transporter EAAT1 Reveals Three Conformationally Sensitive Residues [Articles]
Glutamatergic synaptic transmitters are cleared from the synaptic cleft through excitatory amino ac ...
»Efficient High-Throughput Screening by Endoplasmic Reticulum Ca2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca2+-Release Channels [Articles]
Genetic mutations in ryanodine receptors (RyRs), Ca2+-release channels in the sarcoplasmic reticulu ...
»Restoration of Physiological Expression of 5-HT6 Receptor into the Primary Cilia of Null Mutant Neurons Lengthens Both Primary Cilia and Dendrites [Articles]
5-HT6 (serotonin) receptors are promising targets for a variety of neuropsychiatric disorders and h ...
»Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons [Articles]
9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are two main cannabinoid constituents of marijua ...
»A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells [Articles]
Cytochrome P450 (P450) enzymes are responsible for metabolizing drugs. Expression of P450s can dire ...
»The Temperature Dependence of Kinetics Associated with Drug Block of hERG Channels Is Compound-Specific and an Important Factor for Proarrhythmic Risk Prediction [Articles]
Current mandated preclinical tests for drug-induced proarrhythmia are very sensitive, but not suffi ...


Date published: not known
Details

»Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response
»Evolution of chemokine receptors is driven by mutations in the sodium binding site
»Stochastic shielding and edge importance for Markov chains with timescale separation
»Modeling the functions of condensin in chromosome shaping and segregation
»Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria
»Classification of red blood cell shapes in flow using outlier tolerant machine learning
»Tellurium notebooks—An environment for reproducible dynamical modeling in systems biology
»Nonmechanistic forecasts of seasonal influenza with iterative one-week-ahead distributions
»Mechanical evolution of DNA double-strand breaks in the nucleosome
»Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes
»Cloud computing applications for biomedical science: A perspective
»A biophysical mechanism for preferred direction enhancement in fly motion vision


Date published: not known
Details


THE FOUNDER and CEO

Parham Jabbarzadeh Kaboli, PhD

Research scientist
in molecular medicine


Expert in:

Cell and molecular Biology
Modelling and drug discovery
Cancer signaling pathways

H-index= 3 (Google Scholar)
i10-index= 3
Overall ISI impact factor= 18.15
Overall citation= 110 (Google Scholar)

Memberships:

The American Society for Pharmacology and Experimental Therapeutics (ASPET)

American Association for Cancer Research (AACR)

European Association for Cancer Research (EACR)

American Association for Advancement of Science (AAAS)



CONTACT INFORMATION


Affiliation:
Department of Biomedical Science,
Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
UPM Serdang 43400,
Selangor, Malaysia

E-Mail: parham@gromacs.net
Telegram: telegram.me/parhamacademy
Featured Publication





View the full list.
Archives

Welcome

Username:

Password:



[ ]







This site is powered by Parham Academy.
This site is powered by Parham Academy.
Render time: 0.1818 sec, 0.0268 of that for queries.